Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC — Stella

Home/Esophageal Carcinoma/CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

View on ClinicalTrials.gov

Recruiting

Back to Esophageal Carcinoma trials

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Fudan University Shanghai Cancer Center, Shanghai

Key details

Phase

Large-scale testing

Sponsor

Fudan University

Enrollment target

~452 participants

Started

February 2025

Primary completion

February 2029

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.